These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 2409036)
1. Isoprinosine enhances the activation of sensitized lymphocytes by Epstein-Barr virus antigens. Sundar SK; Barile G; Menezes J Int J Immunopharmacol; 1985; 7(2):187-92. PubMed ID: 2409036 [TBL] [Abstract][Full Text] [Related]
2. Isoprinosine abolishes the blocking factor-mediated inhibition of lymphocyte responses to Epstein-Barr virus antigens and phytohemagglutinin. Sundar SK; Menezes J Int J Immunopharmacol; 1986; 8(1):101-6. PubMed ID: 2420730 [TBL] [Abstract][Full Text] [Related]
3. Isoprinosine restores in vitro T lymphocyte functions of cyclophosphamide immunosuppressed mice. Barasoain I; Rejas MT; Portoles MP; Ojeda G; Rojo JM Int J Immunopharmacol; 1987; 9(4):489-96. PubMed ID: 2442109 [TBL] [Abstract][Full Text] [Related]
4. Generation of Epstein-Barr virus antigen-specific suppressor T cells in vitro. Sundar SK; Menezes J Int J Cancer; 1985 Mar; 35(3):351-7. PubMed ID: 2579037 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of enhancement of Epstein-Barr virus-induced transformation of peripheral blood lymphocytes by a tumor promoter, TPA, with special reference to lowering of cytotoxicity of T cells. Harada S; Katsuki T; Yamamoto H; Hinuma Y Int J Cancer; 1981 May; 27(5):617-23. PubMed ID: 6270019 [TBL] [Abstract][Full Text] [Related]
6. Effect of isoprinosine on in vitro proliferative responses of human lymphocytes stimulated by antigen. Ballet JJ; Morin A; Schmitt C; Agrapart M Int J Immunopharmacol; 1982; 4(3):151-7. PubMed ID: 6179890 [TBL] [Abstract][Full Text] [Related]
7. Modulatory effect of isoprinosine on lymphocyte proliferative response under immunodepressive conditions. Portolés A; Ojeda G; Rojo JM; Portolés MP; Barasoain I J Immunopharmacol; 1983; 5(3):245-56. PubMed ID: 6197489 [TBL] [Abstract][Full Text] [Related]
8. [Action of isoprinosine on the "in vitro" activation of human lymphocytes (author's transl)]. Morin A; Griscelli C; Daguillard F Ann Immunol (Paris); 1979; 130C(4):541-51. PubMed ID: 91345 [TBL] [Abstract][Full Text] [Related]
9. Effects of isoprinosine and NPT 15392 on interleukin-2 (IL-2) production. Wiranowska-Stewart M; Hadden JW Int J Immunopharmacol; 1986; 8(1):63-9. PubMed ID: 2420734 [TBL] [Abstract][Full Text] [Related]
10. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised. Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044 [TBL] [Abstract][Full Text] [Related]
11. Effects of isoprinosine, levamisole, muramyl dipeptide, and SM1213 on lymphocyte and macrophage function in vitro. Hadden JW Cancer Treat Rep; 1978 Nov; 62(11):1981-5. PubMed ID: 83192 [TBL] [Abstract][Full Text] [Related]
12. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture. Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333 [TBL] [Abstract][Full Text] [Related]
13. The effect of isoprinosine on the PHA response of monocyte-depleted and undepleted peripheral blood mononuclear cells. Jacobsen PL; Greenspan JS J Immunopharmacol; 1982-1983; 4(4):355-65. PubMed ID: 6192176 [TBL] [Abstract][Full Text] [Related]
14. Isoprinosine enhances PHA responses and has potential effect on natural killer cell (NK) activity of uremic patients in vitro. Silvennoinen-Kassinen S; Karttunen R; Tiilikainen A; Huttunen K Nephron; 1987; 46(3):243-6. PubMed ID: 2442634 [TBL] [Abstract][Full Text] [Related]
15. Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component. Misko IS; Sculley TB; Schmidt C; Moss DJ; Soszynski T; Burman K Cell Immunol; 1991 Feb; 132(2):295-307. PubMed ID: 1846323 [TBL] [Abstract][Full Text] [Related]
16. Recognition of autologous lymphoblastoid cells by cloned human T cells: inhibition of cytotoxicity by anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen. Hank JA; Sondel PM Hum Immunol; 1984 Apr; 9(4):211-9. PubMed ID: 6201468 [TBL] [Abstract][Full Text] [Related]
17. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells. Konttinen YT; Bluestein HG; Zvaifler NJ J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749 [TBL] [Abstract][Full Text] [Related]
18. Human cytotoxic T lymphocytes (CTL) against Epstein-Barr virus (EBV) infected cells: EBV specificity and involvement of major histocompatibility complex determinants in the lysis exerted by anti-EBV CTL toward HLA-compatible and allogeneic target cells. Lakhdar M; Senik A; Fridman WH Cell Immunol; 1984 Feb; 83(2):414-21. PubMed ID: 6198104 [TBL] [Abstract][Full Text] [Related]
19. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice. Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263 [TBL] [Abstract][Full Text] [Related]
20. Restoration of immune responses of aging hamsters by treatment with isoprinosine. Tsang KY; Fudenberg HH; Gnagy MJ J Clin Invest; 1983 Jun; 71(6):1750-5. PubMed ID: 6190840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]